Browsing: Health

Florida officials are investigating a raw milk outbreak that sickened 21 people, including children, with E. coli and Campylobacter infections across the state.

The FDA escalated Bunge North America’s butter recall to Class II after undeclared milk allergens were found in 64,800 pounds of mislabeled butter.

A University of Pittsburgh study shows artificial sweetener sucralose may reduce immunotherapy effectiveness by altering gut bacteria and T cell activity.

As kratom’s 7-OH compound gains popularity, the FDA moves to ban it, warning of addiction, misuse, and unregulated sales in gas stations and vape shops.

Lenacapavir, a new HIV PrEP injection approved for EU use, shows 99.9% efficacy in global trials, offering the longest protection yet for at-risk groups.

Exposure to persistent PFAS chemicals is now linked to a significant rise in type 2 diabetes, raising concerns over everyday environmental health risks.

NUST MISIS in Russia creates breakthrough 3D-printed larynx implant to support throat structure and help patients recover from advanced cancer stages.

Florida health officials confirm four deaths from Vibrio vulnificus, a rare flesh-eating bacterium linked to warm coastal waters and raw shellfish exposure.

Australian regulators are reviewing a proposal to approve the cultivation and sale of a genetically modified purple tomato, potentially expanding the nation’s limited list of approved genetically modified (GM) crops. If successful, the tomato could be commercially available by next year, with initial production planned in greenhouses in south-east Queensland. Developed by UK-based scientists and commercialized by U.S. firm Norfolk Healthy Produce, the purple tomato has been engineered to contain genes from the snapdragon flower. These genes enable the tomato to produce anthocyanins, naturally occurring antioxidants also found in blueberries, blackberries, and eggplant skins. The resulting pigmentation gives the tomato its distinct purple hue.…

New triple therapy combining inavolisib, palbociclib, and fulvestrant delays breast cancer progression, extends survival, and postpones chemotherapy for patients